Cancer Research UK - Sun exposure at work could lead to one skin cancer death a week
Construction workers had the highest number of deaths (44% of deaths), followed by agriculture workers (23% of deaths).
Public administration and defence workers - including the police and the armed forces - accounted for 10% of deaths.
The researchers, based at Imperial College London (link is external), estimated that there are 48 deaths and 241 cases of melanoma skin cancer each year in Britain caused by ultraviolet (UV) rays from the sun at work.*
Dr Lesley Rushton, lead researcher from Imperial College London, said: “We’ve shown previously that people often don’t understand the risks of damage caused by sun in the UK. But this research shows you don’t have to work in the Mediterranean or a traditionally sunny country for the sun to damage your skin.
“It’s important to get to know what your skin is normally like, and to tell your doctor if you notice any changes to how your skin looks or feels. Skin cancer can appear as a new mole or mark, or it can be a change to something you’ve had for a while.
“Now that we have a clearer picture of the extent of the damage caused, employers need to make sure they take sun exposure at work seriously and work out how to reduce it.”
Sarah Williams, Cancer Research UK’s health information manager, said: “These figures reveal the risk that some people might face from too much sun exposure whilst working. But we need further research to conclude whether sun exposure at work is directly responsible for these skin cancers.The researchers looked at the risk of developing skin cancer for outdoor workers using information from international studies, and the proportion of workers potentially exposed to sun from British data sources. These figures were then used to estimate the number of people who might have developed skin cancer due to work related exposure using a mathematical model.
“We all need some sun for healthy bones, but too much can increase the risk of skin cancer, and the risk can be higher for some people. Generally, the best ways for people to protect their skin is to spend time in the shade between 11am and 3pm, and cover up with clothing. Also use sunscreen with at least SPF 15 and four or more stars on the parts of the body you can’t cover, like face and hands.”
Graham Parker, President of the Institution of Occupational Safety and Health (link is external), said: “This important research was commissioned by IOSH for the Solar phase of our No Time to Lose campaign, which aims to raise awareness of cancer caused by work. We’re delighted to see it published in the British Journal of Cancer. The campaign encourages businesses to do what they can to reduce risks. One way to do this is to develop ‘sun safety strategies’.
“We worked with forward-thinking companies, such as the Royal Mail Group, which signed up to our pledge to help prevent occupational cancer. Royal Mail put in place a sun safety strategy which includes providing wide-brimmed hats, long-sleeved tops and trousers as part of its uniform. It encourages its workers to cover up during the higher UV months. Using high-factor sunscreen is helpful but should not be relied on as the only barrier to the harmful rays.” **
The study was funded by the Institution of Occupational Safety and Health (link is external).
For media enquiries please contact the Cancer Research UK press office on +44 203 469 8300 or, out-of-hours, the duty press officer on +44 7050 264 059.
Rushton et al. The Burden of Occupationally-related Cutaneous Malignant Melanoma in Britain due to Solar Radiation. British Journal of Cancer (2017).
Notes to Editor
*Construction had 21 deaths and 101 melanoma skin cancer cases, agriculture had 11 deaths and 55 cases and public administration had 5 deaths and 26 cases each year. The estimated total is 48 deaths in 2012 and 241 cases in 2011 attributable to sun exposure at work.
**Informed by research, IOSH developed free practical resources to help businesses raise awareness of solar radiation exposure at work. These can be accessed by everyone on its campaign website at www.notimetolose.org.uk/Free-resources/Solar-pack-lite-version.aspx (link is external)
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.